ArticleCancer discovery2021

Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer.

Shuang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.